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Abst rac t
Compression therapy (CT) is an established treatment method in chronic venous disease (CVD). The paper pres-
ents information on different CT forms with indications and contraindications based on expert consensuses from 
recent years. A high prevalence of CVD implies continuous development of compression materials, systems and 
techniques as well as measurement methods. The article aims at reviewing available literature on the development 
of compression therapy techniques. 
Key words: compression therapy, chronic venous diseases, indications, contraindications.
Compression therapy forms
Compression therapy encompasses the use of ho-
siery, bandages, intermittent pneumatic compression 
and complex compression systems. Different types of 
materials of varying elasticity are used together. Cush-
ions, pads, plaster-type bandages, drugs (such as zinc 
oxide), foam and gel dressings are also used in order to 
ensure best possible outcomes and highest achievable 
quality of life [1]. 
The subsequent part of the paper presents basic 
categories of currently used compression products and 
indications for their use. 
Medical compression hosiery
Medical compression hosiery (MCH) is manufactured 
using elastic textiles. They can be flat knit or circular knit. 
Flat knit textiles are thicker and stiffer. The final product 
needs to be sewn together. The circular knit textiles are 
thinner, more delicate and less stiff, with the final product 
of a cylindrical shape. Both methods enable manufactur-
ing of standard and non-standard hosiery products of dif-
ferent lengths: knee-length socks, stockings or tights. Flat 
knit is the preferred manufacturing technique of products 
intended for patients with leg deformity [2, 3]. The selec-
tion criteria include the compression at the ankle level and 
material stiffness. Both parameters are determined by the 
manufacturer [4]. Historically, MCH were chosen based on 
a compression class. However, considering significant dif-
ferences in compression values between these classes in 
different countries, a pressure range (in mm Hg) exerted 
by the product at the ankle level assessed in vitro was pro-
posed as a more uniform criterion [5–7]. Currently, there 
are several compression hosiery classification systems. 
The most common one is the RAL-GZG classification used 
for medical compression hosiery certification. The two re-
maining ones include the CEN classification and the sim-
plified ICC classification (Table 1). There is a lack of agree-
ment on which classification should be universally applied. 
The following recommendations are commonly supported: 
–  the guiding value is the pressure range rather than the 
compression class;
– pressure ranges should be assessed in vitro [8].
Furthermore, the manufacturers of compression 
hosiery are required to provide compression profiles 
[9]. These can be either graduated elastic compression 
stockings (GECS) with a decreasing compression profile 
or progressive elastic compression stockings (PECS) with 
a negative compression gradient. GECS are the standard 
compression therapy. Graduated elastic compression 
stockings (GECS) provide a decreasing pressure profile 
from distal (B point) to proximal (degressive gradient), 
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mimicking physiological pressure distribution (Table 2). 
The PECSs provide a higher compression pressure over 
the C point. The pressure exerted at the C point should 
be about 50% higher than that at the B point [10]. As a re-
sult, PECSs are more effective in increasing the venous 
ejection fraction (EF). Unfortunately, just as GECSs, they 
are unable to restore normal EF, although their clinical 
effect on the EF is close to the one of inelastic bandages 
[4, 10]. PECSs should be worn only during daytime ac-
tivities and removed for resting and at night due to poor 
tolerance and the risk of increased oedema of distal, less 
compressed, leg segments. Currently PECSs are not avail-
able on the market [11]. The commonly used GECSs can 
be divided into thromboprophylaxis stockings (TPS) and 
medical compression stockings (MCS). The TPSs offer 
compression of 15–18 mm Hg and they are indicated for 
use for bedridden or partly ambulant patients, as a part 
of oedema prevention. By reducing the resting vein di-
ameter, TPSs increase venous flow, prevent venous stasis 
and thrombosis. Higher compression MCSs are indicated 
for patients with CVD and abnormal lymph drainage. 
Elastic compression stockings improve the calf muscle 
pump function, reduce the amount of both venous reflux 
and venous volume, in turn normalising ambulatory ve-
nous pressure in limbs with CVI [12]. Based on available 
research and recommendations (last reviewed in 2017), 
MCSs are recommended in specific clinical situations 
(Table 3). 
The SOX trial, in 2013, showed that elastic compres-
sion stockings (ECS) did not prevent post-thrombotic 
syndrome (PTS) after a first proximal DVT [15]. Then, in 
2016, the OCTAVIA study showed that 2 years of com-
pression was more effective than 1 year [16]. Poorer ad-
herence to treatment in the SOX trial was one possible 
reason for its negative result. In turn, the latest IDEAL 
DVT trial [17], which did not include an untreated control 
group, showed that individualized duration of compres-
sion stocking use was as effective as 2.5 years of persis-
tent use after acute DVT. In addition, if one chose to use 
compression stockings in this setting, treatment could be 
limited to 1 year in selected patients.
Elastic stockings are still used for indications not sup-
ported by RCTs, either empirically or based on intuitive 
choices. For example, they are used as a part of preven-
tion in patients with symptomatic or asymptomatic vari-
cose veins [3, 5].
It should be noted that the therapeutic effect of 
MCSs depends on patient compliance [3]. MCSs should 
be put on in the morning and removed at bedtime. They 
should also be replaced after 3–6 months of use, as with 
use, the textiles lose their elastic properties [5]. 
Compression bandages
The key properties of compression bandages are in-
cluded in the PLACE acronym: pressure, layers, compo-
nents, and elastic properties. Compression bandages can 
be divided into long stretch bandages (LSBs) and short 
stretch bandages (SSBs), with the percentage of maxi-
mum stretch as compared to the original length being the 
main classifier. The LSBs have extensibility over 100% as 
compared to less than 100% offered by the SSBs [5]. The 
SSI of LSBs is low (below 10), whereas SSBs have a high 
SSI of over 10 [18]. The SSI measured under the layer of 
extremely inelastic bandage with zinc paste may be as 
high as 40 [19]. The LSBs generate comparable resting 
and standing interface pressure. Body position change 
to standing and muscle contractions only slightly elevate 
the generated pressure [20]. Due to their elastic proper-
ties, the compression does not decrease alongside the 
leg circumference [7]. SSBs provide low resting interface 
pressure which significantly increases in a standing po-
sition and calf muscle pump contractions generate high 
pressure spikes. Pressure differences increase alongside 
the tension force applied during bandaging. As a result, 
the massaging effect is exerted during walking [7, 13, 18, 
Table 1. Medical compression hosiery classification [4, 6, 7]
Level of compression Classification








Moderate 23–32 23–32 20–29
Strong 34–46 34–46 30–39
Very strong > 49 ≥ 49 ≥ 40
The pressure values provided are measured at the B1 point. CEN – Centre Europeen de Normalisation, RAL – Reichs Ausschuss für Lieferbedingungen (State 
Commission for Delivery Terms), ICC – International Compression Club.
Table 2. Graduated elastic compression stockings (GECS) 
– pressure distribution [10]
Measuring point B B1 C
Compression % 100 70–100 50–70
Measuring point B – ankle, measuring point B1 – 10–15 cm above the medial 
malleolus, measuring point C – largest calf circumference.
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20, 21]. Furthermore, compression safety is ensured, es-
pecially in patients with lower extremity artery disease. 
Comparable compression profiles can also be achieved 
with multilayer bandaging or complex compression 
systems (composed of elastic bandages and stiff pads 
or patches) [5]. Using multilayer bandaging or complex 
compression systems increases the stiffness and SSI [19]. 
Applying each additional layer increases the pressure by 
over 50% of the value of its single layer [7]. The stiffness 
also increases as a result of friction between the individ-
ual bandage layers [20]. It is particularly true for adhesive 
bandages which attach to the surface they are applied on 
and cohesive bandages which have low adhesive prop-
erties with a high binding force between the individual 
layers. These properties enable achieving high interface 
pressure, sufficient to prevent pain and bruises after 
surgery and endovascular procedures. The properties of 
adhesive bandages facilitate thigh bandaging [5]. Unlike 
the compression hosiery, which exerts sustained manu-
facturer-declared interface pressure, the pressure gener-
ated by the bandage depends on skills and experience 
of the person to apply it, bandaging technique, tension 
force and number of layers. Whereas patients can ap-
ply LSBs independently, with SSBs, the help of a trained 
healthcare professional or a family member is required 
[20]. Unfortunately, only 10% achieve the target interface 
pressure [19, 22]. The most common error is overly loose 
application, typically seen with SSBs, which – even with 
full initial stretch – tend to lose their haemodynamic 
efficacy within the first hours following application, as 
a result of leg oedema reduction [3, 23]. As soon as 2 h 
following SSB application, the interface pressure drops 
by approximately 30%. SSBs should be reapplied after 
24 h by which the interface pressure has already halved 
[14, 24]. In order to maintain the target interface pres-
sure, new technological solutions are introduced, such 
as compression bandages with printed shapes (ovals or 
rectangles) which turn into circles or squares once tar-
get pressure is applied, or those with line indicator sys-
tems (longitudinal or transverse) which ensure sustained 
pressure and equal layer overlaps. Thus, smart bandages 
are used, into which silver strain gauge transducers are 
knitted, which enable real time measurement of inter-
face pressure [18, 22, 25]. Even though, their application 
varies and the interface pressure values can only be ap-
proximated. There are no specific recommendations as 
to the bandaging technique. Application in a figure-eight 
pattern, in a spiral pattern or using Putter technique is 
Table 3. Clinical indications for graduated elastic compression stockings (GECS) depending on the compression level at 
the B1 point [3–5, 13, 14]
Level of compression 
[mm Hg]
Clinical indications
< 20 • Prevention of oedema of healthy individuals with job-related risk factors (prolonged standing or sitting 
position) and in wheelchair users (Grade 1B) [3]
• Improvement of clinical symptoms of CVD (C0s-C1s, e.g. leg heaviness) of pregnant women with varicose 
veins (Grade 1B) [3]
• Prevention of thromboembolic complications of patients after surgery (ensuring proper hydration and, if 
high-risk, also anticoagulant treatment) (Grade 2C) [3] 
• Thrombosis prevention if anticoagulant treatment is contraindicated (Grade 2B) [3] 
• Keeping the dressing in place in VLU (external ulcer kit layer) 
20–30 • Oedema reduction in patients with CVD and job-associated leg oedema (Grade 1B) [3] 
• Improvement of clinical symptoms and quality of life of patients with CVD and pregnant women with 
varicose veins (Grade 1B) [3]
• In the management of small telangiectases after sclerotherapy in order to achieve better treatment 
outcomes and reduce postoperative complications (pain, oedema, bruising, discoloration) (Grade 2B) [3]
• Prevention of deep vein thrombosis (DVT) in high-risk groups and long-distance travellers (if very high risk, 
MCS and anticoagulant treatment should be used together) (Grade 2B) [3]
• Treatment of acute DVT (to avoid thrombus propagation, reduce severity of clinical symptoms, such as pain 
and oedema, as well as accelerate patient ambulation, directly after diagnosis) (Grade 1B) [3]
• Prevention of post-thrombotic syndrome (PTS) (Grade 1B) [3]
• Treatment of patients with PTS (Grade 1B) [3]
30–40 • After sclerotherapy in order to achieve better treatment outcomes and reduce postoperative complications 
(pain, oedema, bruising, discoloration) – higher efficacy (Grade 1B) [3]
• Symptom severity reduction in lipodermatosclerosis (Grade 1B) [3]
• Treatment of VLU (special ulcer MCS – ‘ulcer kit’): pain reduction, accelerating ulcer healing and reduction 
of VLU recurrence (Grade 1A) [3]
• Treatment of patients with PTS (Grade 1B) [3]
• Maintenance treatment of lymphoedema (Grade 1A) [3]
CVD – chronic venous disease, MCS – medical compression stockings, VLU – venous leg ulcer. Grade description of recommendations: 1A – strong recommen-
dation, high-quality evidence, 1B – strong recommendation, moderate-quality evidence, 1C – strong recommendation, very low-quality evidence, 2A – weak 
recommendation, high-quality evidence, 2B – weak recommendation, moderate-quality evidence, 2C – weak recommendation, very low-quality evidence.
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possible. None of these techniques was shown to be su-
perior to others. SSBs should remain in place for a few 
days, but they should be re-bandaged after 24 h (even 
twice a day) [14, 24]. On the other hand, haemodynami-
cally effective LSBs should be removed for the night due 
to poor tolerance by the patients [5, 20]. There are no 
uniform standards to regulate compression bandaging. 
Standardization was introduced in the UK only, where 
three types of bandages are available. Types 1 and 2 in-
clude lightweight conforming stretch and light support 
bandage used for retention and support, whereas type 
3 is compression bandage [7]. Based on the ICC pre-
standards, four bandage compression levels have been 
distinguished in Europe based on the pressure ranges 
measured at the B1 point (Table 4) [5, 13]. Primarily, the 
need to exert standing pressure over 40 mmHg is an in-
dication for using compression bandages (Table 5) [5]. 
Intermittent pneumatic compression 
Intermittent pneumatic compression (IPC) is a non-
invasive technique with established efficacy in vascu-
lar pathologies [26]. It is a good alternative to other CT 
forms, especially when these are ineffective or cannot be 
used [14]. The IPC devices generate short high-pressure 
waves followed by low-pressure intervals. The intermit-
tent nature and high frequency of pressure spikes enable 
generating pressure values of 120–180 mm Hg, as com-
pared to only 60–70 mm Hg generated by continuous 
compression [21]. Intermittent pneumatic compression 
devices are composed of inelastic sleeve- or boot-shaped 
chamber(s) and electrical pumps with gauges that pro-
vide intermittent compression at predefined target pres-
sures [14, 26]. The compartments are inflated and de-
flated in an alternating manner. The compression force 
may be applied uniformly using a single chamber device, 
whereas the multi-chamber IPC may offer individual or 
sequential chamber inflation. Individual chamber infla-
tion enables delivering predefined pressure to a specific 
area, for example distributing lower pressure over venous 
ulceration [26]. Sequential compression encompasses 
inflating the chambers one-by-one starting at the ankle 
and advancing proximally. 
Sequential compression can be delivered as sequen-
tial pneumatic compression (SPC) or SCD RESPONSE 
Compression System, designed to apply sequential 
compression individually depending on venous return 
and venous outflow obstruction assessed using pleth-
ysmography [27]. SPC can be divided into alternate se-
quential compression (ASC) and simultaneous sequen-
tial compression (SSC) [28]. Actually, there are many SPC 
systems available with different pre-set inflation and 
deflation cycle times and frequently with a possibility to 
adjust cycle times. SCD RESPONSE Compression System 
enables individual adjustment of inflation/deflation cycle 
parameters and increasing the number of cycles per hour 
to approximately 100. It improves the ejection fraction 
volume per hour by 110% [27]. By improving calf muscle 
pump function, venous return and reducing venous sta-
sis, IPC enhances venous blood flow preventing excessive 
venous pressure elevation. Better outcomes are achieved 
with higher compression levels, multi-chamber devices 
or sequential compression [26, 28, 29]. IPC can be used 
even in very severe arterial inflow abnormalities, but de-
vices for arterial insufficiency are different. In addition, 
pressure and cycle times are different in the arterial and 
Table 5. Indications for compression bandaging [1, 13, 21, 23, 24]
Recommendation Comment
VLU treatment Recommendation for strong compression over 40 mm Hg using SSBs (very stiff, completely inelastic 
bandages, for example Unna Boot with zinc paste), and multilayer compression systems including an 
elastic component): faster granulation, reduced exudate, oedema and pain (Grade 1A) [21]
Treatment of mixed arterial 
venous lower extremity ulceration
Recommendation for compression of 30–40 mm Hg using SSBs. Walking training to be used 
alongside. Required measurements: ABPI, pressure measurement at the ankle (> 60 mm Hg) and 
toe (> 30 mm Hg) levels
Treatment of acute DVT (Grade 1B) [21]
Lymphoedema treatment Recommendation for very strong compression > 60 mm Hg. SSBs or compression systems 
composed of SSBs indicated (Grade 1B) [21] 
Reduction of bleeding and 
haematoma formation after 
endovascular procedures
Recommendation for strong compression (Grade 1B) [21]
ABPI – ankle-brachial pressure index, DVT – deep vein thrombosis, SSBs – short stretch bandages, VLU – venous leg ulcer. 
Table 4. Compression bandaging: compression levels [5, 13]
Grade [mm Hg] < 20 20–39 40–59 ≥ 60
Level of compression Low Moderate High Very high
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venous pump [24]. By generating high pressure spikes, 
IPC improves arterial inflow and microcirculation as it 
stimulates vascular endothelial cells as well as enhances 
production and release of vasoactive substances, such 
as nitric oxide. Additionally, it improves release of anti-
inflammatory substances, inhibits lymphocyte adhesion 
and platelet aggregation. Furthermore, it enhances local 
and systemic fibrinolytic activity of the plasma by inhibit-
ing the plasminogen activator inhibitor-1 (PAI-1), and to 
a lesser extent by activating tissue plasminogen activator 
(tPA) [13]. As a result, capillary microcirculation within the 
skin and deeper tissues improves. Increasing the partial 
pressure of oxygen in tissue accelerates VLU healing [21, 
26–28]. IPC reduces limb oedema and improves lymph 
drainage [26, 28]. Its secondary effects include pain relief 
and improved quality of life [28]. There are also reports 
of the effect of IPC on improved bone density [21]. The 
indications for IPC are shown in Table 6. Despite multiple 
advantages, IPC cannot be used in all cases. It is not only 
due to contraindications to widely understood compres-
sion therapy [26]. IPC treatment is generally very safe and 
widely used. Complications of IPC are rare and only single 
reports are available. They resulted usually from misuse 
of IPC. Majority of trials with IPC did not report any sig-
nificant adverse events [30].
When discussing IPC, hybrid devices (adaptive com-
pression therapy) which combine sustained with inter-
mittent pressure, should be mentioned. During activity 
periods, pneumatic pressure chambers compress the leg 
continuously at a constant interface pressure level. Dur-
ing sitting periods, the patient can switch to intermit-
tent pressure. As a result, high efficiency of compression 
therapy is ensured [13].
Adjustable Velcro compression devices 
Adjustable Velcro compression devices (AVCDs) are 
inelastic compression devices with high SSI. They can 
be applied by the patients after a short training course, 
without the help of healthcare professionals. After put-
ting on, the patient adjusts the tension using velcro 
straps. The built-in pressure system and a measuring 
card ensure sustained interface pressure. This addresses 
the interface pressure drop early post-application [13, 14]. 
Owing to their design and simplicity of use, AVCDs can 
be used by elderly individuals, patients with decreased 
muscle force, degenerative joint disease or after total 
knee replacement surgery associated with oedema [14]. 
The key advantages of AVCDs include their reusability, 
ability to trim and wash, safety and no need of involving 
healthcare professionals in their long-term use, which 
decreases treatment costs [14, 31]. AVCDs are indicated 
for treatment of venous oedema and lymphoedema both 
in early treatment stages, to reduce oedema, and in later 
treatment stages to maintain this effect, that is, to pre-
vent recurrence of oedema [14, 31]. AVCDs are more ef-
fective in reducing oedema than SSBs. Compression of 
40 mm Hg with AVCDs corresponds to compression of 
60 mm Hg with SSBs. Furthermore, AVCDs are better tol-
erated by patients [14]. AVCDs are indicated in patients 
with VLUs who are unable to use bandages and show poor 
tolerance of medical compression hosiery [13]. They are 
also an alternative option in thrombosis prevention [31].
Conclusions
The forms of compression therapy discussed in this 
paper constitute the basics. The range of compression 
products is still expanding. New materials of novel prop-
erties, new compression systems as well as technologies 
to maintain and measure the interface pressure are be-
ing developed. Despite this progress, basic principles of 
compression therapy still apply. If clinical indications are 
present, any compression is always better than no com-
pression. The level of compression should be adjusted to 
symptom severity and limited with the value of the mini-
mum effective compression resolving symptoms of CVD 
[3]. Whereas the efficacy of elastic and inelastic materials 
in oedema is similar, the latter offer higher efficacy in 
improving venous haemodynamics [19]. Multicomponent 
compression systems, on the other hand, are the most 
suitable option for severe CVD. Elastic elements included 
in a design of such systems additionally improve their 
efficacy [1]. Compliance is the key to successful com-
pression therapy. Non-compliance is usually associated 
with treatment failure, being one of risk factors for CVD 
Table 6. Indications for intermittent pneumatic compression (IPC) [3, 5, 21, 26, 28]
Recommendation Comment
Local thrombosis prevention An alternative to or complements other thrombosis prevention methods used (Grade 1A) [21]
A method of choice in patients with high risk of haemorrhage 
VLU treatment To be used if no response to standard prolonged (6 months) CT
It reduces VLU size and healing duration and increases the percentage of healed VLUs [26]
Lymphoedema treatment Adjunctive to conventional compression therapy, especially in non-ambulant patients or those with 
lower extremity artery disease (Grade 1B) [21]
DVT prevention (Grade 1A) [21]
CT – compression therapy, DVT – deep vein thrombosis, VLU – venous leg ulcer.
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progression [32]. However, the bottom line of any com-
pression therapy is patient engagement, education and 
compliance. 
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